During the past decade, McGill Cancer Centre at McGill University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 23 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGill Cancer Centre at McGill University" #1 sponsor was "Radiation Therapy Oncology Group" with 24 trials, followed by "Children's Oncology Group" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "NCIC Clinical Trials Group" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill Cancer Centre at McGill University" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 2 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "McGill Cancer Centre at McGill University" are "Head and Neck Cancer" (5 trials), "Prostate Cancer" (5 trials), "Leukemia" (4 trials), "Lung Cancer" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "McGill Cancer Centre at McGill University" in a lesser frequency.

Most popular intervention types in "McGill Cancer Centre at McGill University" are "Drug" (31 trials), "Radiation" (24 trials), "Procedure" (12 trials), "Biological" (7 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (7 trials), "radiation therapy" (7 trials), "cetuximab" (4 trials), "cyclophosphamide" (4 trials) and "doxorubicin hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "McGill Cancer Centre at McGill University" are 36 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "McGill Cancer Centre at McGill University". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in McGill Cancer Centre at McGill University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in McGill Cancer Centre at McGill University, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".